Cargando…
Inhibition of IL-13 and IL-13Rα2 Expression by IL-32θ in Human Monocytic Cells Requires PKCδ and STAT3 Association
Interleukin (IL)-32θ, a newly identified IL-32 isoform, has been reported to exert pro-inflammatory effects through the association with protein kinase C delta (PKCδ). In this study, we further examined the effects of IL-32θ on IL-13 and IL-13Rα2 expression and the related mechanism in THP-1 cells....
Autores principales: | Pham, Thu-Huyen, Bak, Yesol, Oh, Jae-Wook, Hong, Jingi, Lee, Seungyeoun, Hong, Jin Tae, Yoon, Do-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514684/ https://www.ncbi.nlm.nih.gov/pubmed/31010051 http://dx.doi.org/10.3390/ijms20081949 |
Ejemplares similares
-
IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer
por: Bak, Yesol, et al.
Publicado: (2016) -
IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1
por: Kim, Man Sub, et al.
Publicado: (2015) -
Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer
por: Pham, Thu-Huyen, et al.
Publicado: (2019) -
IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production
por: Kim, Man Sub, et al.
Publicado: (2015) -
Investigation on Probable Association Between IL-13, IL-13RA1, and IL-13RA2 Genes Polymorphism and Pulmonary Tuberculosis
por: Li, Hong-Miao, et al.
Publicado: (2022)